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Summary
The R1 subfamily of integrins is thought to play an important role in both the adhesion/migra-
tion and proliferation/differentiation of T cells. Rl integrins can provide T cell costimulation
through interaction of very late antigen (VLA) 4 (VLA-4) (a4R1) and VLA-5 («.Rl) with the
extracellular matrix protein fibronectin (FN), or by VLA-4 binding to its cell surface ligand,
vascular cell adhesion molecule (VCAM) 1. The mechanism by which R 1 integrin members
transduce T cell-costimulatory signals is poorly understood. Studies in non-T cells have dem-
onstrated regulation of the tyrosine focal adhesion kinase pp125FAK by R1 integrin engagement
and, most recently, indicate a role for pp125FAK in linking integrin-mediated signal transduc-
tion to the Ras pathway (Schaller, M. D ., and J. T. Parsons . 1994. Curr. Opin. Cell. Biol. 6:
705-710; Schlaepfer, D . D., S. K. Hanks, T. Hunter, and P. Van der Geer. 1994. Nature
(Lond.). 372:786-790) . Although pp125FAK kinase occurs in T cells, there are no reports on its
regulation in this cell type. The studies described in this article characterize novel regulation of
pp125FAK by the T cell receptor (TCR)-CD3 antigen complex and R1 integrins, and provide
the first account, in any cell type, of integrin ct4(31-mediated pp125FAK tyrosine phosphoryla-
tion. We demonstrate a rapid and sustained synergistic increase in tyrosine phosphorylation of
human pp125FAK in Jurkat T cells after simultaneous (a) triggering of the TCR-CD3 complex,
and (b) x4(31 and 041 integrin-mediated binding of these cells to immobilized FN or et4R] in-
tegrin-mediated binding to immobilized VCAM-1. Studies with normal peripheral blood-de-
rived CD4+ human T blasts confirm the synergistic action ofa TCR-CD3 complex-mediated
costimulus with a FN- or VCAM-1-dependent signal in the induction of T cell pp125FAK ty-
rosine phosphorylation. In vitro kinase assays performed on pp125FAK immunoprecipitates iso-
lated from Jurkat cells and normal CD4+ T cells identified a coprecipitating 57-kD tyrosine-
phosphorylated protein (pp57), distinct from pp59fy" or pp56'1k. These results indicate, for the
first time, the involvement of a specific kinase, pp125FAK in a4R1- and a5Rt-mediated T cell-
costimulatory signaling pathways. In addition, the data demonstrate novel regulation of
pp125FAK tyrosine phosphorylation by the TCR-CD3 complex.
T
he integrins are a family of heterodimeric transmem-
brane proteins, formed by the noncovalent association
ofana subunit and a (3 subunit, that function as cell surface
adhesion receptors for both extracellular matrix (ECM)'
and cell surface protein ligands. There are presently 15 dif-
ferent, structurally related integrin ot subunits and at least 8
different (3 subunits described (1-3) . In adherent cells, inte-
grins localize to focal adhesions, subcellular structures oc-
IAbbreviations used in this paper: ECM, extracellular matrix; FAK, focal ad-
hesion kinase; FN, fibronectin; PDGF, platelet-derived growth factor;
pFN, plasma FN; RGD, Arg-Gly-Asp; SH2, Src homology 2; VCAM,
vascular cell adhesion molecule.
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curring in regions oftight contact between the cell and un-
derlying ECM. Focal adhesions serve as transmembrane
junctions between the ECM and cytoskeleton and consist
of three distinct components: (a) an extracellular compo-
nent made up of ECM proteins; (b) a transmembrane re-
gion comprised of integrin proteins, particularly members
of the R1 family of integrins (very late antigen molecules);
and (c) an array of intracellular cytoskeletal proteins (4) .
The work of Kupfer and co-workers indicates that focal
adhesions occur in T cells at points of contact with APC
and target cells (5-7).
Integrins not only serve as a physical link between the
ECM and cytoskeleton but also appear to be involved in
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tegrins by their extracellular ligands is reported to result in a
number ofintracellular signals, including increases in intra-
cellular pH, intracellular Ca21 concentration, and tyrosine
phosphorylation of cellular proteins, as well as activation of
gene transcription (for reviews see references 1, 2) . A re-
cently described protein tyrosine kinase associated with fo-
cal adhesions, pp125FAK was found to be involved in the
signal transduction pathways mediated by R1 and R3 inte-
grin family members (for reviews see references 8, 9) . Cells
interacting with surfaces coated with variousECM proteins
were found to upregulate the enzyme activity and tyrosine
phosphorylation ofpp125FAK and this up-regulation could
be inhibited by Rl or (33 integrin-specific mAbs . In addi-
tion to integrins, platelet-derived growth factor (PDGF)
(10) and the neuropeptides bombesin, vasopressin, and en-
dothelin (11, 12) were shown to induce tyrosine phospho-
rylation of pp125FAK in 3T3 cells . Recently, ppl25FAK was
reported to physically associate with the cytoplasmic do-
mains of R 1 integrins in vitro (8) .
Several lines of evidence suggest that focal adhesion ki-
nase (FAK) signal transduction may be involved in trans-
mitting signals to both the cytoskeleton and the nucleus .
First, tyrosine phosphorylation of the focal adhesion-asso-
ciated cytoskeletal proteins paxillin and tensin appears to be
dependent upon pp125FAK autophosphorylation on tyrosine
residue (Tyr) 397 (8) . Secondly, the Src family kinases
pp60111, pp59fy", and pp5l"k can bind to pp125FAK through
their Src homology 2 (SH2) domains, and the SH2-depen-
dent pp605'1 binding is also dependent upon autophosphor-
ylation of pp -12511K Tyr397 (13-15) . Lastly, recent studies
show that phosphorylation of pp125FAK Tyr925 promotes
SH2 domain-mediated binding of the kinase to the Grb2
adaptor protein (16) . Thus, current integrin-regulated sig-
naling models link pp125FAK autophosphorylation to changes
in the cytoskeletal architecture and activation of the Ras
pathway of signal transduction (8, 16-18) .
Numerous investigations indicate that R 1 integrins play
an important role in the adhesion/migration and prolifera-
tion/differentiation of T lymphocytes through interaction
of the T cell integrins a4(3 1 (CD49d/CD29) and (X5(3I
(CD49e/CD29) with the CS-1 and Arg-Gly-Asp (RGD)
sites, respectively, on the ECM protein fibronectin (FN)
(for reviews see references 3, 19, 20) . In addition, the inte-
grin aA can also interact with the cell surface ligand vas-
cular cell adhesion molecule (VCAM) 1 (CD106), which is
expressed on inflamed endothelium, follicular dendritic
cells, and tissue macrophages (21, 22) . Binding ofT cell R 1
integrins to FN and VCAM-1 provides signals that are co-
stimulatory with TCR-CD3-mediated signals in inducing
T cell proliferation and cytokine production (23-28) .
Morimoto and colleagues showed that the interaction ofT
cells with FN through (3, integrins induces tyrosine phos-
phorylation ofa 105-kD protein (29) and the up-regulation
of the DNA-binding protein AP-1 . However, beyond
these findings, little is known about the mechanisms by
which P1 integrin-mediated signals are transduced in T
cells .
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Kanner and colleagues demonstrated that human ppl25FAK
is expressed in T cells, that its basal level of tyrosine phos-
phorylation is generally increased in T cell leukemia/lym-
phoma cell lines, and suggested that it is not a component
of the TCR-CD3 signaling pathway (31, 32) . The studies
reported here investigate the regulation ofT cell ppl25FAK
by 0 1 integrin-mediated signaling. We used the purified R 1
integrin ligands FN and VCAM-1 to perform these studies,
and examined Jurkat T cells as well as peripheral blood-
derived CD4+ T cell blasts . Our results show a strong syn-
ergistic effect in signaling through the TCR-CD3 complex
and the a4R1 and ot,Rj integrins, resulting in a rapid and
sustained induction of ppl25FAK tyrosine phosphorylation .
In addition, we describe an unknown tyrosine-phosphory-
lated 57-kD protein (pp57) identified in in vitro kinase as-
says of ppl25FAK-specific immunoprecipitates .
Materials and Methods
Cell Culture.
￿
A subclone from the Jurkat T cell line was kept
in culture at low density (below 106/ml) in RPMI 1640 supple-
mented with 10% FCS, L-glutamine, and antibiotics . The Jurkat
line stains positive in flow cyrometry for the integrins uL
(CD11a), a4 (CD49d), a s (CD49e), R1 (CD29), and RZ (CD18),
as well as forCD2 and CD3 . The adherent murine fibroblast line
3T3 was cultured in DMEM containing 10% FCS, L-glutamine,
and antibiotics . Isolation of purified resting CD4+ T cells was
performed as previously described (33) . Briefly, mononuclear
cells were isolated from bufl-ycoats from healthy donors first by
density centrifugation on a Ficoll gradient, followed by an immu-
nomagnetic negative selection with specific mAbs and magnetic
particles . T cell blasts were obtained by stimulating resting CD4+
T cells with PHA-M, 1 :200 final dilution (GIBCO BRL, Gaith-
ersburg, MD), and 10 ng/ml PMA . On day 3, cells were placed
at low cell density (2 X 10 5/ml) in culture media supplemented
with 100 U/ml rhIL-2 (Hoffman-La Roche, Nutley, NJ) . rhIL-2
was again added on day 6 of culture, after which the cells were
left to rest for another 7-10 d before assaying .
Antibodies and Ligands .
￿
The pp125FAx mAb 2A7 (IgG I ) (34)
and biotinylated antiphosphotyrosine mAb 4G10 were purchased
from Upstate Biotechnology, Inc . (Lake Placid, NY) . The anti-
pp125FAK polyclonal rabbit serum BC3 was kindly provided by
Dr . T . Parsons (University ofVirginia, Charlottesville, VA) (35) .
The ppl25FAK polyclonal rabbit serum hFAK1 was produced by
immunizing rabbits with the KLH-conjugated synthetic peptide
SDEAPPKPSRPGYPSPRSSE (single-letter amino acid code)
corresponding to amino acids 556-575 ofthe human pp125FAK se-
quence (produced by Dr. G . Reddy, Oligopeptide Core Facility,
University of Chicago, Chicago, IL), and was affinity-purified
over a peptide column (31) . Affinity-purified polyclonal anti-
p59>'" rabbit antisera, produced by immunizing rabbits with a glu-
tathione S-transferase fusion protein containing the NH,-termi-
nal 144 amino acids of murine Fyn, was the gift ofDr .M . Clark
(University of Chicago) . Rabbit polyclonal anti-p561" antisera
688 directed against the NHz terminus of p56 1`k was a gift from
Dr . L . E . Samelson (National Institutes of Health [NIH], Be-
thesda, MD) (36) . pp561 Y"mAb was purchased from Transduction
Laboratories (Lexington, KY) . The pp60s" polyclonal rabbit se-
rum generated against the entire chicken pp60'« protein was a gift
from Dr. B . Cobb (University of Chicago) (37) . Murine-derived
mAb mOKT3 (IgG Z,) was obtained from the American Type
Culture Collection (Rockville, MD), and a humanized version
Regulation ofT Cell pp125FAK by the TCR-CD3 Complex and 01 IntegrinshOKT3 (CDR grafted on human IgGI) was provided by Dr. J. A.
Bluestone (University of Chicago) (38). The rat anti-human mAbs
mAb13 (CD29) and mAbl6 (CD49e) were gifts from Dr. K. Ya-
mada (NIH) (39). The NIH49d-1 (CD49d) mAb (IgG,) was gen-
erated by Drs. Y. Tanaka andS. Shaw (NIH). The HP1/2 (CD49d)
mAb was a gift from Dr. R. Lobb (Biogen, Inc., Cambridge, MA)
(40). The mAb 5H7 (human HLA class I) was a gift from Dr. S.
Woodle (University of Chicago) (41) . MOPC-21 (IgG1) was
purchased from Cappel (Organon Teknika, Durham, NC). The
recombinant fusion protein LFA-3-1g, a construct of the extracel-
lular domains of human LFA-3 gene fused to the hinge, CH2,
and CH3 domains of human IgG, was provided by Dr. P. S.
Hochman (Biogen, Inc.) (42). The recombinant fusion protein
VCAM-1-1g, comprised of the two NHZ-terminal domains of
the human VCAM-1 gene fused to the hinge, CH2, and CH3
domains of human IgG,, was produced at Biogen, Inc., as previ-
ously described (43) . Humanplasma FN (pFN) was purchased from
GIBCO BRL.
Cell Stimulation and Preparation of Cell Extracts.
￿
Cells were
stimulated in six-well tissue culture-treated plates (Costar Corp.,
Cambridge, MA) precoated with indicated stimulating antibodies
and/or ligands. Plates were prepared by incubating with indicated
concentrations of antibody/ligand diluted in PBS overnight at
4°C, followed by washing three times with PBS. In experiments
where hOKT3 was one of the stimulatory ligands, all plates were
precoated with goat anti-human IgG (10 Nt,g/ml) . For activation,
cells were washed in PBS and resuspended in serum-free medium
(X-Vivo 20; Biowhittaker, Gaithersburg, MD), and either 2 mil-
lion Jurkat cells or 5-6 million T cell blasts were added to each
well in afinal volume of2 ml. Plates were centrifuged at 200g for
1 min to allow forimmediate contact between cells and antibod-
ies/ligands, and then incubated at 37°C for indicated periods of
time. For harvest, supernatants containing nonadherent cells were
removedand pelleted, and the remaining adherent cells were lysed
in situ in buffer containing 0.5-1% Triton, 50 mM Tris-HCI, pH
7.4, 1,500 mM NaCl, 10 Ft,g/ml aprotinin, 5 wg/ml leupeptin, 1
mM Pefabloc SC (Boehringer Mannheim Corp., Indianapolis,
IN), 2 mM NaVanadate, 2 mM EDTA, 10 mM NaF, and 20
mM iodoacetamide. The adherent cell homogenate was then
added to Eppendorftubes containing pelleted nonadherent cells
from the same wells, and then incubated on ice for 10 min. Cell
membranes were pelleted by microcentrifugation at 4°C for 15
min, and the lysate-containing supernatant was transferred to a
fresh microcentrifuge tube. Conditions indicatedas "resting" rep-
resent cells obtained directly out of suspension culture. These
cells were pelleted, washed once in PBS, pelleted again, and lysed
in Eppendorf tubes, after which membranes were removed by
microcentrifugation.
Immunoprecipitation.
￿
Inununoprecipitations were performed as
described previously (44) . Briefly, cell lysates prepared from equiv-
alent numbers ofJurkat cells (12 X 106 cells) or CD4+ T cell blasts
(^"100 X 106 cells) were precleared (except in blocking studies)
with either protein A- or protein G-Sepharose (ImmunoSelect;
GIBCO BRL) and immunoprecipitated by incubation at 4°C
with antibody preadsorbed to appropriate affinity beads, followed
by washing of immunoprecipitates with lysis buffer before further
analysis.
Western Blotting.
￿
Eluates from cell-equivalent Jurkat cell im-
munoprecipitations or CD4+ T cell blast immunoprecipitations
were separated by SDS-PAGE and electroblotted onto polyvi-
nylidene difluoride membrane. Membranes were blocked in 10%
BSA and blotted with the biotinylated antiphosphotyrosine mAb
4G10 (otpTyr blots) followed by incubation with appropriate
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horseradish peroxidase-conjugated secondary reagent and chemi-
luminescent development according to the manufacturer's in-
structions (Lumiglow; Kirkegaard & Perry Laboratories, Inc.,
Gaithersburg, MD; or enhanced chemiluminescence; Amersham
Corp., Arlington Heights, IL). Where indicated, antiphosphoty-
rosine blots were stripped by 30-min incubation at 56°C in 100
mM [3-2-ME, 2% SDS, and 62.5 mM Tris-HCI, pH 6.8, and ef-
fective stripping was confirmed by incubating blots in developing
reagents and reexposing to autoradiography film. Finally, mem-
branes were washed, blockedin 5% milk, and reblotted with BC3
primary antibody or hFAK1 (otFAK blots). pp125FAx tyrosine
phosphorylation was determined by densitometric scanning of
autoradiograms of otpTyr blots using a computing densitometer
(model 325E; Molecular Dynamics, Inc., Sunnyvale, CA). Values
for pp125FAK tyrosine phosphorylation are expressed relative to a
designated condition in each experiment.
Adhesion Assays.
￿
24-well tissue culture-treated plates (Costar
Corp.) were precoated with stimulating antibodies and/or ligands.
Plates were prepared similarly as for cell activation conditions (see
above). Jurkat cells were washed in PBS, resuspended in serum-
free media, added to tissue culture wells at a density of0.5 million/
well, and incubated at 37°C for 15 min. After incubation, plates
were washed repeatedly with cold PBS, which was removed by
flipping of the plates. Remaining attached cells were quantitated
using a kit (CytoTox 96TM; Promega Corp., Madison, WI) ac-
cording to themanufacturer's guidelines. The assay is based on an
enzymatic reaction ofcytosolic lactate dehydrogenase with a pro-
vided substrate, which results in formation of a red formazan
product that can be read out at 490 nm in an ELISA reader. Per-
cent binding was determined by comparison with a serial dilution
ofJurkat cells as standard.
In Vitro Kinase Assay.
￿
Cells were lysed in 1% Triton X-100
and 0.025% deoxycholate containing lysis buffer and immuno-
precipitated on beads without preclearing. Immunoprecipitates,
representing either 12 X 106 Jurkat cells or 40 X 106 CD4+ T
cell blasts, were washed three times with lysis buffer, once with
TBS (100 mM NaCl, 10 mM Tris, 5 mM MnCl2), and once with
kinase buffer (10 mM Tris, pH 7.4, and 5 mM MnClz). Pellets
were dried thoroughly and resuspended in 20 N.1 kinase buffer
containing 10 RCi [y3=P]ATP (3 .3 N.M, sp act 3,000 Ci/mM;
New England Nuclear, Boston, MA). Samples were incubated
for 20 min at 30°C, washed three times with lysis buffer, boiled 5
min after addition ofsample buffer, resolved by SDS-PAGE, and
detected by autoradiography.
V8 Protease Mapping.
￿
V8 protease mapping was performed us-
ing a modification of the method of Cleveland et al. (45). In vitro
kinase substrates were resolved by SDS-PAGE and visualized by
autoradiography. Bands ofinterest were gel excised, incubated in
pH 6.7 digestion buffer (10% glycerol, 0.1% SDS, 0.125 M Tris,
pH 6.8, 1 mM EDTA) for 30 min at room temperature, and then
placed in wells ofa 12% SDS-PAGE gel with digestion buffer con-
taining 50 lLg/ml Staphylococcus aureus V8 protease (ICN Nutritional
Biochemicals, Cleveland, OH). Digestionbuffer wasoverlayedwith
tracking buffer containing bromophenol blue and subjected to
electrophoresis until the tracking dye was focused within the gel
stack. Power was then turned offfor 30-60 min before comple-
tion of electrophoresis and visualization of digested fragments by
autoradiography.
Results
TCR-mediated and pFN-dependent Signals Can Individually
and Synergistically Induce Tyrosine Phosphorylation ofpp 125F"Kin Jurkat T Cells .
￿
Guan et al . described that, in 3T3 cells,
FN could induce R1 integrin-mediated tyrosine phosphor-
ylation of a 116-kD protein, which was later identified as
pp125FAK (35, 46) . Resting humanT cells, unlike adherent
cells, express surface Rt integrin molecules that do not sup-
port adhesion to ligand-bearing substrate (47) . T cell R 1 in-
tegrin-mediated adhesion can, however, be induced by
various mechanisms, including triggering through theTCR-
CD3 complex or PMA treatment (47) . Consequently, to
study the role ofpp125FAK in R1 integrin-mediated human
T cell costimulation, we initially examined the induction
pp125FAK tyrosine phosphorylation by pFN immobilized
alone or coimmobilized with the C133-specific murine mAb
mOKT3. Experimentswere performed using either the anti-
FakmAb 2A7 or the anti-human Fakpeptide antisera hFAK1
(34) . The specificity ofhFAK1 for pp125FAK was confirmed
in reciprocal preclearing experiments ofJurkat cell lysates
performed with hFAK1 and 2A7 (data not shown) . An-
tiphosphotyrosine (apTyr) Western blots showed that both
2A7 and hFAK1 immunoprecipitates from Jurkat cells stim-
ulated with either pFN ormOKT3 alone displayed modest
tyrosine phosphorylation of a 116-kD protein that was ab-
sent in control immunoprecipitates (Fig. 1 A, lanes 2-5, 8,
and 9), whereas combined pFN and mOKT3 stimulation
resulted in significant synergistic tyrosine phosphorylation
of this protein (Fig . 1 A, lanes 6 and 7) . Western blotting
with BC3 ((xppl25FAK) demonstrated that the 116-kD ty-
rosine-phosphorylated protein comigrated with pp125FAK
and, consequently, will be referred to as pp125FAK in the
remainder of the text (Fig . 1 B) . hFAK1 immunoprecipi-
tates from bulk, unstimulated Jurkat cells demonstrated
three times less tyrosine-phosphorylated pp125FAK than im-
munoprecipitates from cells stimulated with pFN for 10
min (Fig . 1 A, lanes 1 and 3), and six times less tyrosine phos-
phorylation than hFAK1 immunoprecipitates from cells stim-
ulated with mOKT3 (Fig . 1 A, lanes 1 and 5) . Synergistic
R 1 integrin- andTCR-CD3 complex-mediated pp125FAK
tyrosine phosphorylation occurred within 10 min ofinitia-
tion of receptor cross-linking: the amount of pp125FAK ty-
rosine phosphorylation for the combined stimulus ofmOKT3
and pFN at 10 min was 1 .4- and 2 .5-fold higher than the
additive phosphorylation ofpFN alone plus OKT3 alone
for 2A7 and hFAK1 immunoprecipitates, respectively (Fig .
1 A, lanes 2, 4, and 6and lanes 3, 5, and 7) . As hFAK1 was
significantly more efficient than 2A7 in immunoprecipitat-
inghuman pp125FAK, and Western blotting ofimmunopre-
cipitates of either antibody demonstrated similar results,
subsequent experiments were performed with hFAK1 im-
munoprecipitates .
Kinetics of Synergistically Induced pp l25FAK Tyrosine Phos-
phorylation in Jurkat T Cells . Time course studies were
performed to characterize the kinetics of T cell pp125FAK
tyrosine phosphorylation in detail (Fig . 2) . Avery rapid and
synergistic increase in pp125FAK tyrosine phosphorylation
can readily be observed after 1 min of stimulation with
combined mOKT3 andpFN (Fig. 2, top, lane 4), with near
maximum levels occurring by 5 min (Fig . 2, top, lane 7) .
After achieving maximal induction, the level of synergistic
Figure 1 .
￿
TCR-mediated and pFN-dependent signals synergize in ty-
rosine phosphorylation of pp1251AK in Jurkat T cells . JurkatT cells were
either unstimulated (lane 1) or stimulated for 10 min (lanes 2-9) with ei-
therpFN (1 ltg/ml; lanes 2 and 3), mOKT3 (1 l ..g/ml ; lanes 4 and 5), or
a combination of the two (lanes 6-9) . Lysates prepared from 12 X 10`'
cells were immunoprecipitated with either the pp125"-specific niAb
2A7 (lanes 2, 4, and 6) or the human pp125FAK-specific polyclonal serum
hFAK1 (lanes 1, 3, 5, and 7) . Isotype-matched mAb (MOPCI-21) (lane
8) and preimmune sera (lane 9) immunoprecipitates were used as con-
trols . Samples were first analyzed by Western blotting with (A) the an-
tiphosphotyrosine mAb4G10 ((xpTyr blot), followed by strippingand re-
blotting with (B) the anti-ppl25FAK BC3 antiserum ((xFAK blot) . Relative
FAK tyrosine phosphorylation values (determined separately for hFAK1
immunoprecipitations and 2A7 immunoprecipitations) were as follows :
hFAK1 immunoprecipitations, bulk 0.04, pFN 0.14, mOKT3 0.25,
mOKT3 + pFN 1 ; 2A7 immunoprecipitations, pFN0.21, mOKT30.52,
mOKT3 + pFN 1 .
pp125FAK tyrosine phosphorylation was maintained for at
least 2 h (Fig. 2, top, lanes 10, 13, 16, and 19) .
Both a4(31- and a5a1 Integrin-mediated Signals Induce Ty-
rosine Phosphorylation ofT Cell pp 125FAK . For further spec-
ificity analysis, we tested other purified ligands capable of
interacting with theJurkat T cells for their ability to induce
pp125FAK phosphorylation . In addition to pFN, which
contains per molecule twoRGD sites for a5R1 binding and
one CS-1 site for x4(3 1 binding, we tested the x4(3 1 integrin
ligand VCAM-1 (CD106) and the CD2 ligand LFA-3
(CD58) (Fig . 3 A) . VCAM-1 and LFA-3 were used as re-
combinant human Ig fusion proteins and immobilized indi-
rectly through goat anti-human IgG . The hOKT3 mAb
that was used is a humanized (IgG1) version of the murine
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Tyrosine phosphorylation ofpp125FAK in T cells is induced
rapidly and maintained for at least 2 h . (Top) Jurkat T cells were either
unstimulated (lane 1) or stimulated for indicated periods with either pFN
(1 ltg/ml; lanes 2, 5, 8, 11, 14, and 17), mOKT3 (1 la,g/ml; lanes 3, 6, 9,
12, 15, and 18), or a combination ofthe two (lanes 4, 7, 10, 13, 16, and
19) . Lysates prepared from 12 X 106 cells were immunoprecipitated with
hFAKl antisera and subjected to Western blotting with the antiphospho-
tyrosine mAb 4G10 (apTyr blot) . (Bottom) Mean relative ppl25FAx ty-
rosine phosphorylation as determined from two independent experi-
ments. Values for the mean and standard deviation at each time point
were as follows : pFN, 0.11 ± 0.04 (1 min), 0.14 ± 0.04 (5 min), 0.28 ±
0.18 (15 min), 0.13 ± 0.07 (30 min), 0.19 ± 0.04 (1 h), and 0.12 ± 0.05
(2 h) ; for mOKT3, 0.04 ± 0.02 (1 min), 0.15 ± 0.16 (5 min), 0.16 ±
0.14 (15 min), 0.07 ± 0.02 (30 min), 0.15 ± 0 .1 (1 h), and 0.14 ± 0.01
(2 h) ; for mOKT3 + pFN, 0.36 ± 0.01 (1 min), 0.84 i' 0.15 (5 min),
0.73 ± 0.09 (15 min), 0.85 ± 0.21 (30 min), 0.85 ± 0.09 (1 h), and 0.91
0.12 (2 h) . Measurements were determined relative to the highest level of
Fak tyrosine phosphorylation observed in each experiment .
mAb mOKT3 . Together, pFN and hOKT3 demonstrated
the same synergistic effect on pp125FAK tyrosine phosphor-
ylation as was shown previously (Fig . 3 A, top, lanes 1-3) .
VCAM-1 alone was capable of inducing tyrosine phosphor-
ylation of pp125FAK to levels similar to those achieved by
the combination ofpFN and hOKT3 (Fig. 3 A, top, lanes 3
and 4) . A threefold synergistic increase in these levels oc-
curred whenVCAM-1 was costimulated with hOKT3 (Fig .
3 A, top, lanes 1, 4, and 5) . The combination of hOKT3
and LFA-3 did not induce pp125FAK tyrosine phosphoryla-
tion over the level obtained with hOKT3 alone (Fig . 3 A,
top, lanes 1 and 7), even though the CD2-LFA-3 pathway
is functional in this particular Jurkat subclone as indicated
by the induction of IL-2 secretion (data not shown) .
To identify the T cell pFN receptors involved in the
pp125FAK tyrosine phosphorylation, we performed mAb
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blocking studies (Fig . 3 B) . The greatest inhibition (^ "90%
inhibition) of combined mOKT3-pFN-induced pp125FAK
tyrosine phosphorylation was observed after blocking with
either a Pt-specific mAb (Fig . 3 B, top, lanes 3 and 8) or the
combination of a4- and as-specific mAbs (Fig . 3 B, top,
lanes 3 and 7) . No blocking was seen with control mAb
against a nonpolymorphic determinant ofHLA class I (Fig .
3 B, top, lanes 3 and 4) . The ae 4-specific mAb alone partially
blocked ppl25FAK tyrosine phosphorylation (Fig . 3 B, top,
lanes 3 and 5), as did the a5-specific mAb (Fig . 3 B, top,
lanes 3 and 6) . The pp125FAK tyrosine phosphorylation re-
maining after PI-specific mAb blocking approximated that
found with mOKT3 alone (Fig. 3 B, top, lanes 2 and 8) .
Together, these results indicate that the synergistic effect of
combined mOKT3 and pFN stimulation on the induction
of pp125FAK tyrosine phosphorylation in Jurkat cells is
completely mediated by R1 integrins and, more specifically,
is the result ofboth a4R1- and a5R1-mediated interactions .
The VCAM-1-dependent increase in tyrosine phospho-
rylation of pp125FAK was also examined to determine the
integrin receptors involved. The data shown in Fig. 3 C in-
dicate that the dominant integrin receptor involved in
combined hOKT3-VCAM-1-induced tyrosine phosphor-
ylation of pp125FAK is a4R1, as both the a4-specific mAb
(Fig . 3 C, top, lane 5) and the Rt integrin-specific mAb
(Fig . 3 C, top, lane 7) could block induction down to levels
achieved with hOKT3 alone (Fig. 3 C, top, lane 1) . As ex-
pected, mAbs against the as integrin (Fig . 3 C, top, lane 6)
or HLA class I (Fig . 3 C, top, lane 4) did not alter the
ppl25FAK tyrosine phosphorylation induced by coimmobi-
lized hOKT3 and VCAM-1 (Fig . 3 C, top, lane 3) .
FACScan© cytofluorometric analysis of the Jurkat T cells
showed that they expressed high levels of integrins a4
(CD49d) and 0 1 (CD29) and significantly lower levels of
integrin a; (CD49e), and were negative for the mAb
ACT-1 (data not shown), which recognizes a conforma-
tional epitope on 007 (48) . Although the a4R7 integrin is
reported to mediate adhesion to FN and VCAM-1 (49,
50), these findings exclude a potential a role for 047-
mediated induction of ppl25FAK tyrosine phosphorylation
in these Jurkat cells .
PMA-induced Increased Adhesion ofJurkat Cells to FN Does Not
Lead to Increased Tyrosine Phosphorylation ofT Cell pp125FAK.
We postulated that the synergistic effect ofTCR-CD3 com-
plex- and pFN-mediated signals on the regulation ofT cell
ppl25FAK tyrosine phosphorylation was due to augmention
of01 integrin signaling as a result ofTCR-CD3-mediated
enhancement of R1 integrin adhesion to pFN . To investi-
gate this hypothesis, we examined whether the phorbolester
PMA, another reported enhancer of 01 integrin-mediated
T cell adhesion to pFN, would augment both binding of
the Jurkat cells to pFN and pFN-induced tyrosine phos-
phorylation of ppl25FAK (Table 1) (47) . As depicted in Ta-
ble 1, although PMA significantly enhanced adhesion of
Jurkat cells to pFN, it did not affect pFN-mediated tyrosine
phosphorylation ofFAK. These results indicate that increased
binding ofJurkat cells to pFN will not necessarily result in
enhanced ppl25FAK tyrosine phosphorylation .Figure 3 .
￿
(A) The integrin ligands pFN and VCAM-1 can synergize with a TCR-mediated
signal in inducing tyrosine phosphorylation ofT cell pp125 1" . (Top) Jurkat T cells were stiniu-
lated for 15 min with either hOKT3 (0 .1 N,g/nil) alone (lane 1), or the ligands pFN (1 lag/ml),
VCAM-1-Ig (0 .3 Ltg/ml), LFA-3-Ig (1 ltg/ml) alone (lanes 2, 4, and 6), or in combination with
hOKT3 (lanes 3, 5, and 7) . All plates were precoated with goat anti-human IgG (10 N,g/nil) .
hFAK1 immunoprecipitates prepared from 12 X 106 cells were analyzed by Western blotting
with the antiphosphotyrosine mAb 4G10 ((xpTyr blot) as described . (Bottom) ppl25FAK tyrosine
phosphorylation expressed relative to the value obtained with combined hOKT3 and VCAM-1
stimulation . Bars represent mean and SD of three independent experiments . (B) The otA and
a s (3, integrins are both involved in pFN-dependent tyrosine phosphorylation of T cell pp125FAK .
(Top) The mAbs 5H7 (HLA class I mAb ; lane 4), HPl/2 (integrin a 4 ; lanes 5 and 7), InAb16 (in-
tegrin a ; ; lanes 6 and 7), and mAb13 (integrin (3, ; lane 8) were tested for their ability to block
mOKT3 + pFN-induced pp125FAK tyrosine phosphorylation . In each condition, 10 Ia,g/ml (final
concentration) o£blocking mAb was added to each well ofa mOKT3 + pFN-coated six-well tis-
sue culture plate before the addition of 2 X 10 6Jurkat cells per well . hFAK1 immunoprecipitates
of each condition were analyzed by Western blotting as described above (Fig. 3 A) . (Bottom)
pp125FAK tyrosine phosphorylation expressed relative to the value obtained with combined
mOKT3 and pFN stimulation in the absence ofblocking mAbs . Bars represent mean and SD of
three independent experiments . (C The integrinuA, not a ;(3,, is involved in VCAM-1-depen-
dent tyrosine phosphorylation of T cell ppl25FAK . (Top) The mAbs (HLA class-I mAb; lane
4), HPl/2 (integrin a4 ; lane 5), mAb16 (integrin a s ; lane 6), and mAb13 (integrin R, ; lane 7)
were tested for their ability to block hOKT3 + VCAM-1-induced pp125FAK tyrosine phos-
phorylation . Blocking studies were performed and analyzed as described above (Fig. 3 A) ex-
cept that, before washing and addition of blocking mAbs, plates were incubated for 30 min
with 10 ILg/ml of human immunoglobulin to bind unbound goat anti-human Ig Fc . (Bottom)
pp125FAK tyrosine phosphorylation expressed relative to the value obtained with combined hOKT3 and VCAM-1 stimulation in the absence of
blocking mAbs . Bars represent the mean and SD of three independent experiments .
pp125FAK Immunoprecipitate-associated pp57.
￿
The role of
pp125FAK in T cell signaling is not yet clear . Consequently,
in vitro kinase assays were performed to identify pp125FAK-
associated kinase substrates that may be members ofknown
signaling pathways . Two specific bands, ^116 and 57 kD,
were identified as kinase substrates in both 2A7 and hFAK1
immunoprecipitates from Jurkat cells incubated on plates
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coated with mOKT3 and pFN and 2A7 immunoprecipi-
tates from tissue culture flask-adherent 3T3 cells (Fig . 4 A,
lanes 1, 2, and 5, and data not shown) . Presumably, the 116-
kD band represents phosphorylated pp125FAK . As pp125FAK
has been reported to associate with both pp605" and pp59f>",
a principal tyrosine kinase in T cells, experiments were per-
formed to determine if pp59fy" associates with ppl25FAK in
Regulation ofT Cell pp125FAK by the TCR-CD3 Complex and (3, IntegrinsTable 1 .
￿
Effects ofPMA onJurkat Cell Adhesion topFNand
Tyrosine Phosphorylation ofpp 125FAK
Relative FAK
￿
Percentage cells
tyrosine phosphorylation*
￿
adherent*
pFN
￿
0.15 (±0.1)
￿
1 (±1.4)
pFN +PMA
￿
0.11 (±0.06)
￿
43(--9.8)
In all experiments, PMA was added at 10 ng/ml final concentration to
the medium, mOKT3 andpFNwere both coated at 1 jig/ml, andJur-
kat cells were stimulated for 15 min at 37 °C .
*Tyrosine phosphorylation of pp125FAK was determined by Western
blots ofhFAKI immunoprecipitates as described . Themean and SD of
three independent experiments are shown and expressed relative to
FAK tyrosine phosphorylation in the condition pFN + hOKT3 = 1 .
$Adhesion results are expressed as the mean and SD of two indepen-
dent experiments .
Jurkat cells and represents the lowerpp57 band observed in
in vitro kinase studies (13) . Jurkat cells activatedwith mOKT3
andpFN and immunoprecipitated with one ofthree differ-
ent pp59fv° antibodies and one pp56
<<k antibody revealed no
Figure 4.
￿
A phosphorylated 57-kD protein (pp57), distinct from pp59fy°
and pp561 , is detected in human T cell ppl25FAx-specific immunopreci-
pates. (A) In vitro kinase assay oflysates from Jurkat T cells stimulated for
15 min with a combination of pFN (1 N,g/ml) and mOKT3 (1 N,g/ml)
and immunoprecipitated with either the pp125FAK-specific mAb 2A7
(lane 1), the human pp125FAK-specific polyclonal serum hFAK1 (lane 2),
a Fyn-specific antiserum (lane 3), a Lck-specific antiserum (lane 4), or
control preimmune serum (lane 5) . The specific immunoprecipitates were
subjected to in vitro kinasing with [y32P]ATP and resolved by SDS-
PAGE, followed by autoradiography. Arrows indicate the anti-ppl25FAx_
specific pp116 and pp57 bands . (B) V8 protease analysis of phosphopro-
teins identified from in vitro kinase reactions depicted in Fig. 4A. The
specific bands analyzed were the 57-kD-specific band from 2A7
(pp57[2A7]) andhFAKl (pp57 [hFAK1]) immunoprecipitates (lane 1 and
2, respectively), the 59-kD-specific band from anti-Fyn immunoprecipi-
tates (pp59 [Fyn]) (lane 3) and the 59- and 56-kD-specific bands from
Lck immunoprecipitates (pp59 [Lck] and pp56 [Lck]) (lanes 4 and 5, re-
spectively) . Specific bands were cut out and subjected to V8 protease di-
gestion, followed by resolution by SDS-PAGE and autoradiography.
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coprecipitating pp125FAx protein by Western blot analysis
with the anti-pp125FAx antibody BC3 (data not shown) .
This failure of Western blot analysis to reveal an association
between pp125FAK and pp59fy" does not preclude the possi-
bility ofthe pp57 band representing pp59fy", because ofthe
high specific activity oflabeling in the in vitro kinase assays .
Therefore, V8 protease digests of in vitro kinase-labeled
pp59fy" and pp56"" proteins were compared with similar di-
gests of pp57 to look for similarities (Fig. 4, A and B) . Jur-
kat T cells were stimulated for 10 min with the combina-
tion ofmOKT3 and pFN, lysed, and immunoprecipitated
with 2A7, hFAK1, anti-pp59fy" antisera, anti-pp561 anti-
sera, anti-pp605" antisera, and anti-pp56'Y" mAb. The specific
immunoprecipitates were used as substrates in in vitro ki-
nase reactions and run out on SIDS-PAGE . The pp60"c and
pp56'Y" antibodies failed to precipitate kinase activity from
the Jurkat lysate (data not shown) . In contrast, strongly la-
beled specific bands, which approximated butwere not iden-
tical in molecular mass to thepp125FAK_specific pp57 band,
were obtained from the kinase-labeled pp59fy" and pp56~ek
immunoprecipitates (Fig . 4 A, lanes 3 and 4) . The pp57 band
in the 2A7 and hFAK1 immunoprecipitates and the phos-
phorylated band of 59 kD (pp59) in the pp59fy" immuno-
precipitate were cut out ofthe gel and used for V8 protease
digest analysis . The pp56 1`k immunoprecipitate showed two
major phosphorylated bands at 59 (pp59) and 56 kD (pp56),
which were both cut out and subjected to V8 protease di-
gestion . The V8 protease digest analysis revealed that, whereas
the phosphopeptide map of pp57 from the 2A7 immuno-
precipitates was almost identical to that of hFAK1-derived
pp57 (Fig. 4 B, lanes 1 and 2), it was clearly distinct from
the pp59 (Fyn), pp59 (Lck), and pp56 (Lck) maps (Fig. 4 B,
lanes 3-5) . These results indicate that T cell pp57 represents
neither pp59fy" nor pp56<<k protein tyrosine kinase .
In vitro kinase-labeled pp116 (pp125FAK) and pp57 de-
rivedfrom both 2A7 and hFAK1 immunoprecipitates were
analyzed to determine the specific phosphoamino acid con-
tent . Phosphoamino acid analysis indicated that pp116
(pp125FAK) and pp57 were, in both cases, almost exclu-
sively tyrosine phosphorylated (data not shown) .
pp125FAK Tyrosine Phosphorylation andpp57 in Normal Hu-
man Peripheral Blood-derived CD4+ T Cells . To ascertain
whether the findings on ppl25FAx regulation derived from
studies with theJurkat cell line could be extended to nor-
mal CD4+ T cells, we performed a set o£ experiments on
resting human peripheral blood-derived CD4+ T cell
blasts . Fig . 5, A and B, shows the results ofthe effect ofvar-
ious stimulatory conditions on pp125FAK tyrosine phosphor-
ylation in normal resting CD4+ T cell blasts . The data con-
firm the results found in the Jurkat T cell line, namely,
optimal Rt integrin ligand (pFN and VCAM-1)-induced
pp125FAK tyrosine phosphorylation requires a TCR-CD3-
mediated costimulus .
pp57 was also found in normal peripheral blood-derived
CD4+ T cell blasts . In vitro kinase assays onhFAK1 immu-
noprecipitates from hOKT3 plus pFN-stimulated CD4+ T
cell blasts show the ppl16 and pp57 bands observed in sim-
ilarly stimulated Jurkat T cells (data not shown) .Figure 5 .
￿
A TCR-mediated signal synergizes with both pFN- and VCAM-1-dependent signals in the induction of tyrosine phosphorylation of
ppl25FAK in human peripheral blood-derived CD4+ T cell blasts . (A) (Top) Western blot analysis ofhFAKI-immunoprecipitated lysates derived from
90 X 10° CD4+ T cell blasts (lanes 1-3) and 12 X 10'Jurkat T cells (control ; lane 4) stimulated for 15 nun with either hOKT3 (0 .1 Wg/nil; lane 1), pFN
(1 lag/ml; lane 2), or a combination of the two (lanes 3 and 4) . (Bottom) pp125FAK tyrosine phosphorylation expressed relative to the value obtained with
combined mOKT3 and pFN stimulation . Bars represent the mean and SD of two independent experiments . (B) (Top) 115 X 10 6 CD4* T cell blasts
(lanes 1-6) were unstimulated (lanes 1 and 2) or stimulated for 15 min with eitherhOKT3 (0 .1 N.g/ml; lane 3), VCAM-1 (0.3 lig/ml; lane 4), or a com-
bination of the two (lanes 5 and 6), immunoprecipitated with hFAKI (lanes 1, 3, 4, 5, and 7) or preimmune serum (lanes 2 and 6), and subjected to
Western blot analysis . Jurkat T cells (control ; lane 7) were stimulated with hOKT3 + pFN . (Bottom) ppl25FAK tyrosine phosphorylation expressed relative
to the value obtained with combinedhOKT3 and VCAM-1 stimulation . Bars represent the mean and SD ofthree independent experiments . For both A
and B, immunoprecipitated lysates were subjected to Western blot analysis with the antiphosphotyrosine mAb 4G10 (etpTyr blot) followed by the anti-
pp125FAK antisera BC3 ((YFAK blot) as described in Materials and Methods .
Discussion
Work with purified FN and VCAM ligands has demon-
strated that R, integrins can provide costimulatory signals
for human T cells (for review see reference 19) . However,
the mechanism by which these R, integrin-mediated sig-
nals are transduced in T cells is poorly understood . In non-
lymphoid cells, signaling through P, integrins was recently
shown to induce tyrosine phosphorylation and increased
enzyme activity of the tyrosine kinase pp1251AK (51, 52) .
Tyrosine-phosphorylated pp125FAK i s reported to associate
with a number of established signal-transducing molecules,
including the Src family tyrosine kinases pp60 5" and pp59tyn,
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phosphatidylinositol 3-kinase, and the adaptor protein Grb2
(3, 15, 16, 53) .
We present here, for the first time, data demonstrating
the involvement of pp125FAK in costimulatory signal trans-
duction through (3 t integrins in human T cells . We also
provide the first description of integrin aaRt-mediated reg-
ulation of pp125FAK tyrosine phosphorylation . Our results
show that engagement ofT cell Rt integrin by natural ligand
(pFN orVCAM-1) results in pp125FAK tyrosine phosphoryla-
tion. In addition, we demonstrate that, in contrast to naturally
adherent cells, a synergistic effect on pp125FAK tyrosine phos-
Regulation ofT Cell ppl25FAK by the TCR-CD3 Complex and (3, Integrinsphorylation can be achieved when a costimulus, specifically
TCR-CD3 cross-linking, is provided concomitantly with R1
integrin engagement. Lastly, we describe a tyrosine-phos-
phorylated 57-kD protein (pp57) present in ppl25FAK-spe-
cific immunoprecipates.
Resting primary T cells express x4(31 and a5R1 integrin
receptors that do not effectively bind their ligands, as deter-
mined by the inability of these integrins to promote adhe-
sion of T cells to appropriate ligand-bearing substrates (26,
47). R1 integrin-mediated adhesion can, however, be
achieved in T cells after CD3-TCR cross-linking, PMA
treatment, or stimulation with certain chemokines (47, 54,
55). Consequently, although we found that incubation of
T cells with either immobilized pFN or VCAM-1 could
induce tyrosine phosphorylation ofpp125FAK we reasoned
that the magnitude of this induction would significantly in-
crease if the (3t integrin ligands were coimmobilized with
OKT3 mAb. Our results demonstrate that, in both Jurkat
cells and human CD4+ T cell blasts simultaneous R1 inte-
grin-mediated binding to pFN or VCAM-1 and triggering
of the TCR-CD3 complex does indeed result in synergis-
tic tyrosine phosphorylation of pp125FAK. However, we
also found that incubation of T cells with immobilized
OKT3 alone induces low but significant levels of pp125FAK
tyrosine phosphorylation. This finding suggests the possi-
bility that the costimulatory effect of OKT3 on pFN- or
VCAM-1-induced pp12511K tyrosine phosphorylation may
not be due soley to TCR-mediated induction of R1 inte-
grin binding. In this regard, it is interesting to note that ty-
rosine phosphorylation ofpp125FAK in 3T3 cells is reported
to occur not only as a result of integrin engagement, but
also after treatment with growth hormone (PDGF) (10)
and neuropeptides (bombesin, vasopressin, and endothelin)
(11, 12). In addition, we observed that, although treatment
ofJurkat cells with PMA results in increased cell adhesion
to pFN, it does not lead to increased pFN-induced tyrosine
phosphorylation ofpp125FAK (Table 1) . Faull et al. recently
reported that, although both PMA treatment and TCR-
CD3 cross-linking induced increased adhesion of T cell
lines to immobilized FN through cx5p1, only TCR-CD3-
mediated activation induced high-affinity integrin receptors
as defined by the ability of these receptors to bind soluble
FN (56) . Taken together, this report and our data suggest
the possibility that, in T cells, only high-affinity R1 integrin
binding is capable of inducing tyrosine phosphorylation of
pp125FAK. An alternative (or additional) explanation for the
synergistic action of TCR-CD3 complex- and R1 integrin-
mediated signals on pp125FAK tyrosine phosphorylation may
derive from the data of Cobb et al. characterizing the asso-
ciation between tyrosine-phosphorylated pp125FAK and the
tyrosine kinases pp60s'1 and pp59f" in chick embryo cells
(13, 57). A model consistent with these data is that TCR-
CD3 complex triggering results in activation and colocal-
ization of pp59f" (or another Src-family kinase member),
with pp125FAK leading to association of the two kinases and
either (a) direct pp59f'"-mediated tyrosine phosphorylation
of pp125FAK and/or (b) maintenance of pp125FAK tyrosine
phosphorylation as a result of pp59fy" SH2 domain binding,
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rendering FAK resistant to the action of endogenous tyro-
sine phosphatases. Although we have not been able to dem-
onstrate an association between pp1251 and pp59f'" in Jur-
kat cells, it is possible that such an association does existbut
is below our level of detection. Further detailed studies on
this complex and important issue are in progress.
Brugge and co-workers showed that a11A-mediated ty-
rosine phosphorylation ofpp125FAK in platelets requires not
only binding to fibrinogen but also ADP as cofactor (58) .
Interestingly, 001 -mediated tyrosine phosphorylation of
pp125FAK in platelets binding to collagen did not require
such a costimulus. Synergistic pp125FAK tyrosine phosphor-
ylation has also been reported after FN adherence and
FcERI aggregation of a rat basophilic leukemia cell line
(59). As discussed above, our results show that, in T cells,
R1 integrin-mediated coupling to the pp125FAK pathway
requires costimuli for optimal tyrosine phosphorylation of
pp125FAK. Together, these data and our findings suggest the
existence of critical differences in requirements for inte-
grin-mediated pp125FAK tyrosine phosphorylation, depen-
dent on both the specific integrin subfamily member and
the cell type involved.
pp125FAK tyrosine phosphorylation occurs rapidly and is
sustained in Jurkat cells stimulated with coimmobilized
OKT3 and pFN. Maximal tyrosine phosphorylation is
achieved -5-15 min after initiation of stimulation and is
maintained at high levels for at least 2 h. The rapid induc-
tion of T cell pp125FAK tyrosine phosphorylation suggests
the possibility that pp125FAK-mediated signaling might play
a role in short-lived T cell interactions, such as those oc-
curring when cytotoxic T cells engage their targets or when
migrating T cells adhere to endothelium and extravasate into
tissue. In contrast, the sustained kinetics of tyrosine phos-
phorylation might be indicative of a T cell-costimulatory
function of pp125FAK, as it appears that prolonged interac-
tion between T cells and costimulatory ligand-bearing APC
is required for downstream proliferation to occur.
Experiments with blocking antibodies and specific re-
combinant ligands demonstrated the direct involvement of
R1 integrins in tyrosine phosphorylation ofpp125FAK. More-
over, they confirmed a role for the integrin cx5R1 and indi-
cated a previously undescribed participation ofx4(31 integrin
in pp125FAK regulation. The finding that combined inhibition
by the a4- and cx5-specific mAbs was similar to that achieved
by the R1-specific mAb alone indicates that the 001 and asR1
integrins can account for all the pFN-induced R1 integrin-
mediated tyrosine phosphorylation of pp125FAK in Jurkat
cells. Blocking experiments with specific mAbs in Jurkat
cells stimulated with coimmobilized VCAM-1 and OKT3
mAb indicated an exclusive role for the integrin cx4R1 in
the increased VCAM-1-mediated tyrosine phosphorylation
of pp 125FAK.
In vitro kinase experiments and phosphoarnino acid
analyses identified a single, specific 57-kD tyrosine phos-
phoprotein (pp57) associated with pp125" immunopre-
cipitates from both Jurkat cells and CD4+ T blasts. In ad-
herent cells, pp125FAK has been reported to associate with
several proteins that may be tyrosine phosphorylated invitro, including members of the Src family of protein ty-
rosine kinases (pp60s", pp59fyn, and pp50"') and the cyto-
skeletal protein paxillin (8, 13, 15, 16). Obvious candidates
for pp57, based on their molecularmass, ability to be phos-
phorylated or autophosphorylate on tyrosine, and their
prominent roles in T cell signaling, were the Src family
members pp59fyn and pp56j`k. However, V8 protease digest
analyses indicated that both pp59fyn and pp561,k could be
eliminated as likely pp57 candidates. We were unable to
precipitate kinase activity from Jurkat lysates with either
pp605"- or pp56ty"-specific antibodies. Based on its molecu-
lar mass, pp57 is not likely to represent pp50" or paxillin.
A phosphorylated species of similar molecular mass to pp57
has been identified in pp125FAx immunoprecipitates from
thrombin-treated platelets incubated with [-y32P]ATP (51).
The presence of pp57 in T cells as well as non-T cells sug-
gests that pp57 may be a component of the Fak signaling
pathway common to many cell types.
We describe findings on the synergistic involvement of
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mediate induction of pp125FAKtyrosine phosphorylation in the human H9 T cell line (Nojima, Y., K. Tach-
ibana, T. Sato, S. F. Schlossman, and C. Morimoto. 1995. Cell. Immunol. 161:8-13).
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the TCR-CD3 complex and the integrins aA and ats[3,
in regulation of human T cell pp125FAx tyrosine phosphor-
ylation. Recently, we have observed a direct correlation
between synergistic pp125" tyrosine phosphorylation and
synergistic mitogen-activated protein tyrosine kinase acti-
vation and IL-2 production in Jurkat cells costimulated
with OKT3 and either FN or VCAM-1 (data not shown) .
These results complement earlier findings in Jurkat cells
demonstrating that aA integrin stimulation promotes ac-
cumulation of GTP-bound Ras (18) . Together, these data
suggest that adherent cell models linking R, integrin-
dependent pp125FAx tyrosine phosphorylation to activation
of the Ras signaling pathwaymight also apply to T cells. In
conclusion, the results presented in this article indicate a
potential role for the pp125FAx signaling pathway in trans-
ducing a,R,- and a501 -derived T cell-costimulatory sig-
nals and expand the list ofregulators of pp125FAK to include
the TCR-CD3-signaling complex.
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